» Articles » PMID: 19827119

Extracapsular Spread in Oral Squamous Cell Carcinoma

Overview
Journal Head Neck
Date 2009 Oct 15
PMID 19827119
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Extracapsular spread (ECS) in the cervical lymph nodes represents the most significant adverse prognostic indicator in oral squamous cell carcinoma (OSCC).

Methods: In a consecutive cohort of OSCC treated by primary surgery, ECS was seen in 25% (101) of 400 patients.

Results: ECS doubled the incidence of local recurrence and distant metastases, but tripled regional failure. The recurrences occurred sooner in ECS than in non-ECS cases (206 vs 334 days, p = .04). Patients with macroscopic ECS had a 5-year overall survival (OS) of 19% compared with 31% in microscopic ECS. MRI neck staging offered poor sensitivity, especially in microscopic ECS. Age >75 years, smoking, and heavy use of alcohol were independent predictors of ECS, which may implicate a failure of immunosurveillance by the host as much as adverse biology of the tumor.

Conclusions: Reporting of ECS is essential in accurate prognostication, and we advocate that all patients with OSCC and ECS should be grouped as pN3 on the basis of their prognosis. (c) 2009 Wiley Periodicals, Inc. Head Neck, 2010.

Citing Articles

Mitosis - predicting primary tumour and metastatic lymph node behaviour and beyond in OSCC - A pilot study.

Makarla S, Bavle R, Topajiche S J Oral Maxillofac Pathol. 2025; 28(4):602-611.

PMID: 39949704 PMC: 11819642. DOI: 10.4103/jomfp.jomfp_292_24.


Nodal assessment and extranodal extension in head and neck squamous cell cancer: insights from computed tomography and magnetic resonance imaging.

Maggialetti N, Villanova I, Greco S, Sardaro A, Lagrasta M, Dipalma C Radiol Med. 2024; 130(2):202-213.

PMID: 39580776 DOI: 10.1007/s11547-024-01929-1.


Resection status and margin control in intraoperative frozen sectioning analysis of oral squamous cell carcinoma.

Neumann F, Straub X, Mrosk F, Rubarth K, Wolfsberg J, Piwonski I Oral Maxillofac Surg. 2024; 28(3):1209-1218.

PMID: 38532169 PMC: 11330392. DOI: 10.1007/s10006-024-01238-x.


Prediction of prognosis in oral squamous cell carcinoma using infrared microspectroscopy.

Whitley C, Ellis B, Triantafyllou A, Gunning P, Gardner P, Barrett S Cancer Med. 2024; 13(5):e7094.

PMID: 38468595 PMC: 10928453. DOI: 10.1002/cam4.7094.


Has the 8th American joint committee on cancer TNM staging improved prognostic performance in oral cancer? A systematic review.

Erazo-Puentes M, Sanchez-Torres A, Aguirre-Urizar J, Bara-Casaus J, Gay-Escoda C Med Oral Patol Oral Cir Bucal. 2024; 29(2):e163-e171.

PMID: 38368527 PMC: 10945871. DOI: 10.4317/medoral.25983.